Come up with a name for your new list and we'll add to it:
Da Volterra raised a round of funding on September 22, 2017. Investors include
European Investment Bank.
Da Volterra's research is dedicated to understanding the impact of antibiotics on the intestinal flora, and developing solutions against Gram-negative bacterial pathogens.…